.png)
Yokogawa’s life science business started in 1996 with the development of innovative instruments based on proprietary confocal microscopy technologies, and is dedicated to providing novel products employing microscopy and/or image analysis technology for the advancement of cell biology research and drug discovery. The company’s portfolio includes the Confocal Spinning Disk Unit (CSU), CellVoyager™ High Content Analysis Systems and Software, and the new Single Cellome™ portfolio for nano-point delivery and subcellular sampling.
Yokogawa provides advanced solutions in the areas of measurement, control, and information to customers across a broad range of industries, including energy, chemicals, materials, pharmaceuticals, and food. Yokogawa addresses customer issues regarding the optimization of production, assets, and the supply chain with the effective application of digital technologies, enabling the transition to autonomous operations. Founded in Tokyo in 1915, Yokogawa continues to work toward a sustainable society through its 17,000+ employees in a global network of 122 companies spanning 61 countries.
About Yokogawa Europe B.V.
The European headquarters of Yokogawa were founded in Amersfoort in the Netherlands in 1982. Throughout Europe Yokogawa has its own sales, service, and engineering operations. This dedicated network has been extended to Central and East Europe to further enhance the coverage and support associated with serving the process control and automation marketplace. Yokogawa develops and produces flowmeters at Rota Yokogawa in Germany and liquid analyzers and industrial safety systems in the Netherlands. In addition to the network of Yokogawa subsidiaries, a select number of Channel Partners are available in certain areas to support specific customer needs of this continuously developing market.